Clinical Trial

An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma

Name: An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma — clinical trial record (NCT07200375)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GlofitReal

Recruiting

View on ClinicalTrials.gov →

Summary

This study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).

Protocol Amendment History 1 change

notable Trial sites expanded: 12 -> 15 locations 2026-04-04

Trial Details

NCT Number	NCT07200375
Lead Sponsor	Hoffmann-La Roche
Conditions	Diffuse Large B-Cell Lymphoma
Enrollment	300 participants
Start Date	2025-09-29
Primary Completion	2029-09-29 (estimated)
Study Completion	2029-09-29 (estimated)
Updated on ClinicalTrials.gov	2026-08-06